These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 806790)

  • 1. [The therapeutic value of "Essential" phospholipids].
    Pristautz H
    MMW Munch Med Wochenschr; 1975 Apr; 117(14):583-6. PubMed ID: 806790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effect of Ciba 13437-Su in 40 patients with familial essential hyperlipemia].
    Schönbeck M; Forster G; Hirzel H; Jakab T; Rosenmund H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1761-8. PubMed ID: 5451984
    [No Abstract]   [Full Text] [Related]  

  • 3. [Action of "essential" phospholipids on plasma lipids and fatty acids in type II hyperlipoproteinemias].
    Peeters H; Blaton V; Soetewey F; Declercq B; Vandamme D
    Munch Med Wochenschr; 1973 Aug; 115(31):1358-62. PubMed ID: 4741079
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modification of disordered coronary and peripheral circulation using essential phospholipids].
    Pristautz H; Pavek P; Klein W
    Wien Med Wochenschr; 1974 Nov; 124(44):644-8. PubMed ID: 4428784
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the administration of exogenous phospholipids in dyslipidemic patients].
    Ravielle A; Delise P; Totaro G; Piccolo E
    Clin Ter; 1978 Sep; 86(5):441-9. PubMed ID: 737968
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of tocopherol nicotinate on serum lipids].
    Aigner O; Schlick W
    Int J Clin Pharmacol; 1974 Sep; 10(2):124-8. PubMed ID: 4448553
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study with a new antihyperlipemic combination].
    Pistautz H
    Arzneimittelforschung; 1977; 27(1):152-6. PubMed ID: 576816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of serum lipids in normal persons and patients with essential hypertension with reference to carbohydrate metabolism].
    Lüthy R
    Praxis; 1969 Oct; 58(43):1365-72 contd. PubMed ID: 5395158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes of serum lipids in coronary diseases during treatment with long-acting nitrobodies].
    Klein WW; Pristautz H; Pavek P; Brandt D; Fluch N; Borkenstein J
    Z Kardiol; 1974 Aug; 63(8):713-8. PubMed ID: 4422388
    [No Abstract]   [Full Text] [Related]  

  • 11. Familial hyper-pre-betalipoproteinemia with observations on the metabolism of endogenous particles.
    Rose HG
    J Lab Clin Med; 1970 Jul; 76(1):92-102. PubMed ID: 5425367
    [No Abstract]   [Full Text] [Related]  

  • 12. [Action of purified phospholipids on the serum lipid pattern].
    Tralli G
    Clin Ter; 1977 Mar; 80(6):545-51. PubMed ID: 862355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone therapy in women in the menopause transition. Randomised, double-blind, placebo-controlled trial of effects on body weight, blood pressure, lipoprotein levels, antithrombin III activity, and the endometrium.
    Khoo SK; Coglan MJ; Wright GR; DeVoss KN; Battistutta D
    Med J Aust; 1998 Mar; 168(5):216-20. PubMed ID: 9539899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasmatic coagulation factors in hyperlipoproteinemias].
    Zöller H; Fromme K; Gross W
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):201-4. PubMed ID: 4360448
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of essential phospholipids (Essliver Forte) on the level of cholesterol and blood serum lipoproteins in bile duct diseases].
    Kozlova NM; Tiuriumin IaL; Kulinskiĭ VI; Leonova ZA
    Eksp Klin Gastroenterol; 2006; (6):73-6. PubMed ID: 17612099
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids.
    Best MM; Duncan CH
    Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.